EICHORCondition: Attention Deficit/Hyperactivity Disorder · Sponsor: Corium, Inc.
The is a multicenter, dose-optimized, open-label, safety/ tolerability and pharmacokinetic (PK) study with Azstarys® in children 4 and 5 years of age with attention-deficit/hyperactivity disorder (ADHD). The primary objective is to determine the safety and tolerability of treating children 4 and 5 years-of-age with ADHD with Azstarys® for up 12 months. Approximately 100 subjects will be enrolled. Approximately 20 sites will participate.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Preferred Research Partners (PRP) | Little Rock, Arkansas, United States | — |
| Advanced Research Center (ARC) | Anaheim, California, United States | — |
| IMMUNOe International Research Center | Centennial, Colorado, United States | — |
| Clinical Neuroscience Solutions - Orlando | Jacksonville, Florida, United States | — |
| Accel Research Sites - Lakeland | Lakeland, Florida, United States | — |
| Accel Research Sites - Maitland | Maitland, Florida, United States | — |
| South Florida Research Phase I-IV INC | Miami Springs, Florida, United States | — |
| CNS Healthcare - Orlando | Orlando, Florida, United States | — |
| iResearch Atlanta | Decatur, Georgia, United States | — |
| CenExel iResearch, LLC | Savannah, Georgia, United States | — |
| Sky Clinical Research Network Group P.C. | Union City, Georgia, United States | — |
| DelRicht Research - Touro Medical Center | New Orleans, Louisiana, United States | — |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05721235